Oil

Oil
Oil

Dow Jones rises 96 points as Iran tensions keep Wall Street cautious

Wall Street’s main indexes were muted on Monday, as stalled peace talks between the United States and Iran and rising oil prices kept investors cautious ahead of a crucial week for earnings and monetary policy. The S&P 500 slipped about 0.04%, while the Nasdaq Composite declined 0.28%. On the other hand, Dow Jones Industrial Average

Read More
Oil

Hormuz shipping muted amid US-Iran tensions; freight rates split

Shipping data on Monday indicated that at least seven vessels, primarily dry bulk carriers, traversed the Strait of Hormuz over the last 24 hours.  This level of activity is consistent with the subdued pace observed recently, occurring as talks between Iran and the United States remain stalled. According to ship tracking data from Kpler and

Read More
Oil

Arbitrum price outlook amid push for unfreezing of Kelp DAO exploit funds

Arbitrum’s ecosystem is at the center of a major DeFi recovery effort, with leading protocols urging the Arbitrum DAO to unfreeze roughly 30,766 ETH (worth about $71 million) linked to the Kelp DAO exploit. With the funds now locked in a DAO-controlled address, decision-making power has effectively shifted to Arbitrum governance. DeFi players urge Arbitrum

Read More
Oil

Qualcomm stock price at risk of a crash despite OpenAI partnership rumors

Qualcomm stock price surged by over 12% on Monday as investors cheered a potential partnership with OpenAI ahead of its much-anticipated financial results on Wednesday this week. QCOM jumped to $160, its highest point since January 2026 and 29% above its lowest level this year. Qualcomm partnership with OpenAI The QCOM stock price soared after

Read More
Oil

Commodity wrap: US-Iran stalled talks boost Brent crude 2%; gold slips

Oil prices edged up more than 2% on Monday as peace talks between the US and Iran stalled, while shipments through the Strait of Hormuz remained muted.  Gold and silver dropped as energy prices climbed sharply, raising fears about higher inflation and elevated interest rates.  The metals market is experiencing a subdued opening to the

Read More
Oil

Strategy (MSTR) buys $255M BTC as rally faces demand concerns

Strategy (previously known as Microstrategy) expanded its Bitcoin holdings last week, purchasing an additional 3,273 BTC for approximately $255 million, even as analysts flagged concerns about the sustainability of the recent price rally. The acquisition, disclosed in an 8-K filing with the US Securities and Exchange Commission, was made at an average price of $77,906

Read More
Oil

Nvidia stock wobbly after hitting record high, but analysts see more upside

Shares of Nvidia rose in early trading on Monday, extending a breakout rally that has pushed the stock to record highs. However, at the time of writing, shares of the chip maker had given up most of those gains to trade mostly flat. Investors are looking ahead to a key week of earnings from major

Read More
Oil

Why is the price of Katana crypto rising and how far can it climb?

Katana (KAT) has been one of the strongest-performing altcoins in the market over the past 24 hours, recording a sharp 73.1% jump to $0.02129. What makes this rally stand out is not just the price increase, but the scale of trading activity behind it. KAT has significantly outperformed Bitcoin and the broader crypto market, which

Read More
Oil

Why is Skillz stock crashing despite major legal victory?

Investors are bailing on Skillz (NYSE: SKLZ) on Friday morning despite the company securing a monumental $420 million jury verdict in its high-stakes litigation against Papaya Gaming. The federal jury in Manhattan ruled that Papaya had engaged in systematic false advertising by using “bots” in its skill-based games, misleading players into thinking they were competing

Read More
Oil

Lilly stock falls as Foundayo trails Novo’s Wegovy in early uptake

Shares of Eli Lilly came under pressure on Friday after early prescription data for its newly launched weight-loss pill suggested a slower rollout compared with rival Novo Nordisk’s competing product. According to data from healthcare analytics firm IQVIA, Lilly’s Foundayo recorded 3,707 prescriptions in the US during its second week on the market, up from

Read More